Immuron Receives AUD $358,280 R&D Tax Concession Refund

    NEXT STORY
    Pyrogen Testing Market by Product & Service, Test Type, End-user and Region – Global Forecast to 2025
    PREV STORY
    Correction to previous pressrelease: Active Biotech updates its clinical strategy and projected milestones
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Inovio Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 7, 2018

    PLYMOUTH MEETING, Pa., July 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced ...

    author_avatar
    NASDAQ Market News

    ASHP Recognizes Memorial Hospital Pharmacy with National Award

    author_avatar
    NASDAQ Market News

    Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS)

    Phase 3 elacestrant study has opened for enrollmentFast Track designation from the FDA for ...

    author_avatar
    NASDAQ Market News